Literature DB >> 20562525

Distinct time courses of secondary brain damage in the hippocampus following brain concussion and contusion in rats.

Yuko Nakajima1, Yutaka Horiuchi, Hiroshi Kamata, Masayoshi Yukawa, Masato Kuwabara, Takashi Tsubokawa.   

Abstract

Secondary brain damage (SBD) is caused by apoptosis after traumatic brain injury that is classified into concussion and contusion. Brain concussion is temporary unconsciousness or confusion caused by a blow on the head without pathological changes, and contusion is a brain injury with hemorrhage and broad extravasations. In this study, we investigated the time-dependent changes of apoptosis in hippocampus after brain concussion and contusion using rat models. We generated the concussion by dropping a plumb on the dura from a height of 3.5 cm and the contusion by cauterizing the cerebral cortex. SBD was evaluated in the hippocampus by histopathological analyses and measuring caspase-3 activity that induces apoptotic neuronal cell death. The frequency of abnormal neuronal cells with vacuolation or nuclear condensation, or those with DNA fragmentation was remarkably increased at 1 hr after concussion (about 30% for each abnormality) from the pre-injury level (0%) and reached the highest level (about 50% for each) by 48 hrs, whereas the frequency of abnormal neuronal cells was increased at 1 hr after contusion (about 10%) and reached the highest level (about 40%) by 48 hrs. In parallel, caspase-3 activity was increased sevenfold in the hippocampus at 1 hr after concussion and returned to the pre-injury level by 48 hrs, whereas after contusion, caspase-3 activity was continuously increased to the highest level at 48 hrs (fivefold). Thus, anti-apoptotic-cell-death treatment to prevent SBD must be performed by 1 hr after concussion and at latest by 48 hrs after contusion.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20562525     DOI: 10.1620/tjem.221.229

Source DB:  PubMed          Journal:  Tohoku J Exp Med        ISSN: 0040-8727            Impact factor:   1.848


  8 in total

1.  Post-trauma administration of the pifithrin-α oxygen analog improves histological and functional outcomes after experimental traumatic brain injury.

Authors:  L-Y Yang; Y-H Chu; D Tweedie; Q-S Yu; C G Pick; B J Hoffer; N H Greig; J-Y Wang
Journal:  Exp Neurol       Date:  2015-03-24       Impact factor: 5.330

Review 2.  Hemorrhagic progression of a contusion after traumatic brain injury: a review.

Authors:  David Kurland; Caron Hong; Bizhan Aarabi; Volodymyr Gerzanich; J Marc Simard
Journal:  J Neurotrauma       Date:  2011-12-05       Impact factor: 5.269

Review 3.  A critical review of radiotracers in the positron emission tomography imaging of traumatic brain injury: FDG, tau, and amyloid imaging in mild traumatic brain injury and chronic traumatic encephalopathy.

Authors:  Cyrus Ayubcha; Mona-Elisabeth Revheim; Andrew Newberg; Mateen Moghbel; Chaitanya Rojulpote; Thomas J Werner; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-07-21       Impact factor: 9.236

Review 4.  Cell Death and Recovery in Traumatic Brain Injury.

Authors:  Yosuke Akamatsu; Khalid A Hanafy
Journal:  Neurotherapeutics       Date:  2020-04       Impact factor: 7.620

5.  Cognitive impairments accompanying rodent mild traumatic brain injury involve p53-dependent neuronal cell death and are ameliorated by the tetrahydrobenzothiazole PFT-α.

Authors:  Lital Rachmany; David Tweedie; Vardit Rubovitch; Qian-Sheng Yu; Yazhou Li; Jia-Yi Wang; Chaim G Pick; Nigel H Greig
Journal:  PLoS One       Date:  2013-11-28       Impact factor: 3.240

6.  Spontaneous nervous system concussion in dogs: a description of two cases and a review of terminology in veterinary medicine.

Authors:  Angelo Pasquale Giannuzzi; Antonio De Simone; Mario Ricciardi
Journal:  Open Vet J       Date:  2017-11-06

7.  Moderate hypothermia inhibits microglial activation after traumatic brain injury by modulating autophagy/apoptosis and the MyD88-dependent TLR4 signaling pathway.

Authors:  Fengchen Zhang; Haiping Dong; Tao Lv; Ke Jin; Yichao Jin; Xiaohua Zhang; Jiyao Jiang
Journal:  J Neuroinflammation       Date:  2018-09-20       Impact factor: 8.322

8.  A double-blind, placebo-controlled intervention trial of 3 and 10 mg sublingual melatonin for post-concussion syndrome in youths (PLAYGAME): study protocol for a randomized controlled trial.

Authors:  Karen M Barlow; Brian L Brooks; Frank P MacMaster; Adam Kirton; Trevor Seeger; Michael Esser; Susan Crawford; Alberto Nettel-Aguirre; Roger Zemek; Mikrogianakis Angelo; Valerie Kirk; Carolyn A Emery; David Johnson; Michael D Hill; Jeff Buchhalter; Brenda Turley; Lawrence Richer; Robert Platt; Jamie Hutchison; Deborah Dewey
Journal:  Trials       Date:  2014-07-07       Impact factor: 2.279

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.